0001483813-13-000098.txt : 20130916 0001483813-13-000098.hdr.sgml : 20130916 20130916184624 ACCESSION NUMBER: 0001483813-13-000098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130913 FILED AS OF DATE: 20130916 DATE AS OF CHANGE: 20130916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS INC CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121-1345 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121-1345 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATTON JOHN STUART CENTRAL INDEX KEY: 0001247653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 131099759 MAIL ADDRESS: STREET 1: 150 INDUSTRIAL ROAD STREET 2: C/O NEKTAR THERAPEUTICS CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-09-13 0 0001159036 HALOZYME THERAPEUTICS INC HALO 0001247653 PATTON JOHN STUART C/O HALOZYME THERAPEUTICS, INC. 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121 1 0 0 0 Common Stock 2013-09-13 4 M 0 100000 0.39 A 230000 D Common Stock 2013-09-13 4 S 0 37500 9.1029 D 192500 D Common Stock 2013-09-16 4 S 0 37500 9.1648 D 155000 D Option to Purchase Common Stock (NSO) 0.39 2013-09-13 4 M 0 100000 0.39 D 2004-12-09 2013-12-09 Common Stock 100000 0 D This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.07 to $9.17. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price. This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.075 to $9.24. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price. By: Jean Liu, Attorney-in-fact For: John Stuart Patton 2013-09-16